HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Parlux S&E

This article was originally published in The Rose Sheet

Executive Summary

Net sales for fiscal 2003 (ended March 31) increased 3.2% to $72.3 mil. and net income was $5.5 mil. Com-pared to a net loss of $5.7 mil. the prior year, Parlux Fragrances announces June 27. Results include pre-tax income of $4 mil. relating to the proceeds from the settlement of a lawsuit against a supplier filed in 2001, company states, noting prior-year loss was due primarily to non-cash charge of $7.4 mil. related to the impairment of intangibles in connection with sale of two brands and a $2.9 mil. non-cash charge for an unrealized loss on investment. Current borrowings are at historic low of approximately $4.9 mil. compared to $11.5 mil. a year ago, Perry Ellis, Jockey and Ocean Pacific fragrance marketer adds...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011342

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel